📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Insanabilis

1.1 - Company Overview

Insanabilis Logo

Insanabilis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical research, development, and commercialization of medically innovative therapies for serious diseases with no or limited treatment options; venture-capital financed.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Insanabilis

Processa Pharmaceuticals Logo

Processa Pharmaceuticals

HQ: United States Website
  • Description: Provider of drug product development to improve patient survival and quality of life, with a pipeline spanning oncology and GI: PCS6422 to improve chemotherapy safety/effectiveness in metastatic colorectal cancer; PCS11T for colorectal, small cell lung, and pancreatic cancers; PCS3117 for pancreatic cancer (FDA Orphan Designation); PCS499 for Ulcerative Necrobiosis Lipoidica; PCS12852 for gastroparesis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Processa Pharmaceuticals company profile →
Jerini Logo

Jerini

HQ: Germany Website
  • Description: Provider of SPOT technology via fee-for-service project work for pharmaceutical and biotech companies, originating as a 1994 spin-off from the Medical Faculty (Charité) Humboldt University Berlin.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Jerini company profile →
DNage Logo

DNage

HQ: The Netherlands Website
  • Description: Provider of life sciences research and development focused on discovering and developing products for aging diseases caused by DNA damage.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DNage company profile →
ProFactor Pharma Logo

ProFactor Pharma

HQ: United Kingdom Website
  • Description: Provider of recombinant blood factors for haemophilia, including a low-cost, GMP-optimized recombinant human Factor VIII (rhFVIII) for Haemophilia A. Offers a patent-protected cell line and production process delivering higher yields and lower costs, and collaborates with Bio Farma Persero on scale-up, clinical trials planned to commence in 2024, and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ProFactor Pharma company profile →
Artelo Biosciences Logo

Artelo Biosciences

HQ: United States Website
  • Description: Provider of endocannabinoid system modulating therapeutics, including ART27.13, a synthetic dual CB1/CB2 GPCR agonist intended to increase appetite and reduce muscle wasting; ART26.12, a selective fatty acid binding protein inhibitor with potential in cancer and chemotherapy-induced peripheral neuropathy; and ART12.11, a proprietary cannabidiol–tetramethylpyrazine cocrystal designed to improve CBD's pharmaceutical properties.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Artelo Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Insanabilis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Insanabilis

2.2 - Growth funds investing in similar companies to Insanabilis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Insanabilis

4.2 - Public trading comparable groups for Insanabilis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Insanabilis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Insanabilis

What does Insanabilis do?

Insanabilis is a provider of biopharmaceutical research, development, and commercialization of medically innovative therapies for serious diseases with no or limited treatment options; venture-capital financed.

Who are Insanabilis's competitors?

Insanabilis's competitors and similar companies include Processa Pharmaceuticals, Jerini, DNage, ProFactor Pharma, and Artelo Biosciences.

Where is Insanabilis headquartered?

Insanabilis is headquartered in United States.

How many employees does Insanabilis have?

Insanabilis has 1,000 employees 🔒.

When was Insanabilis founded?

Insanabilis was founded in 2010 🔒.

What sector and industry vertical is Insanabilis in?

Insanabilis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Insanabilis

Who are the top strategic acquirers in Insanabilis's sector and industry

Top strategic M&A buyers and acquirers in Insanabilis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Insanabilis?

Top strategic M&A buyers groups and sectors for Insanabilis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Insanabilis's sector and industry vertical

Which are the top PE firms investing in Insanabilis's sector and industry vertical?

Top PE firms investing in Insanabilis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Insanabilis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Insanabilis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Insanabilis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Insanabilis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Insanabilis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Insanabilis?

The key public trading comparables and valuation benchmarks for Insanabilis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Insanabilis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Insanabilis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Insanabilis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Insanabilis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Insanabilis's' sector and industry vertical?

Access recent funding rounds and capital raises in Insanabilis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Insanabilis